Literature DB >> 1710114

Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation.

J A Mitchell1, U Förstermann, T D Warner, J S Pollock, H H Schmidt, M Heller, F Murad.   

Abstract

Endothelium-derived relaxing factor (EDRF) released from endothelial cells (EC) has been shown to be nitric oxide (NO) or a closely related molecule. In cultured EC, the enzyme responsible for the formation of EDRF, EDRF-synthase, was initially described as being cytosolic, but more recently we have found it to be predominantly particulate. In view of this discrepancy we have investigated the EDRF synthesizing activity of cytosolic and particulate fractions isolated from native bovine aortic EC. EDRF was measured by cGMP formation in rat fetal lung cultured fibroblasts (RFL-6) and by the ability of cell fractions to relax endothelium-denuded, preconstricted rabbit aortic strips. Cytosolic fractions from native EC (100 micrograms) had no effect on the tone of rabbit aortic strips and little effect on cGMP levels in RFL-6 cells in the presence of L-arginine and NADPH (100 microM). However, under the same conditions the 100,000 x g pellet fractions relaxed rabbit aortic strips and increased cGMP levels in RFL-6 cells. Thus EDRF synthase from native EC, like those grown in culture, is located mainly in the particulate fraction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710114     DOI: 10.1016/0006-291x(91)90444-c

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.

Authors:  J A Mitchell; H Sheng; U Förstermann; F Murad
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

2.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.

Authors:  J S Pollock; U Förstermann; J A Mitchell; T D Warner; H H Schmidt; M Nakane; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms.

Authors:  D R Springall; V Riveros-Moreno; L Buttery; A Suburo; A E Bishop; M Merrett; S Moncada; J M Polak
Journal:  Histochemistry       Date:  1992-11

4.  Different patterns of release of endothelium-derived relaxing factor and prostacyclin.

Authors:  J A Mitchell; G de Nucci; T D Warner; J R Vane
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

5.  Noradrenergic-nitrergic interactions in the rat anococcygeus muscle: evidence for postjunctional modulation by nitric oxide.

Authors:  L Kasakov; A Belai; M Vlaskovska; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

6.  3,4-Methylenedioxymethamphetamine alters left ventricular function and activates nuclear factor-Kappa B (NF-κB) in a time and dose dependent manner.

Authors:  David A Tiangco; Sapna Halcomb; Frank A Lattanzio; Barbara Y Hargrave
Journal:  Int J Mol Sci       Date:  2010-11-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.